Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 20 of 28 found articles
 
 
  Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF)
 
 
Title: Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF)
Author: Udelson, James E.
Lewis, Gregory D.
Shah, Sanjiv J.
Zile, Michael R.
Redfield, Margaret M.
Burnett Jr, John
Mittleman, Robert S.
Profy, Albert T.
Seferovic, Jelena P.
Reasner, David
Konstam, Marvin A.
Appeared in: American heart journal
Paging: Volume 222 () nr. C pages 183-190
Year: 2020
Contents:
Publisher: Elsevier Inc.
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 20 of 28 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands